Postpartum Diabetes Screening Before and during The Covid-19 Pandemic: A Single Institutional Study
Gestational diabetes mellitus (GDM) is known to be a predictive factor in the development of type 2 diabetes mellitus in affected mothers and their offspring. Current guidelines recommend a 2-hour postpartum glucose tolerance test (OGTT) in patients with history of GDM. However, compliance rates for ordering and completion has been reported as suboptimal. The COVID-19 pandemic has had significant impact on healthcare systems requiring the adaptation of novel strategies to manage patients. So far, there is paucity of data on how this impact compliance rates for the oral glucose tolerance test. We aimed to explore the compliance rate for ordering the OGTT and the prevalence of impaired fasting glucose in our patient population before and during the pandemic. Overall, we report a low compliance for 5-year period with further reduction observed during the pandemic. In addition, we observed higher prevalence of impaired fasting glucose during the pandemic. Future studies will explore factors that may have contributed to these observations.
Keywords - Gestational Diabetes, Diabetes Mellitus, Glucose Tolerance, Postpartum Glucose Screening.